Cytokines suppress human islet function irrespective of their effects on nitric oxide generation

D L Eizirik1, S Sandler, N Welsh

  • 1Department of Medical Cell Biology, Uppsala University, Sweden.

Insights

Cytokines can damage human beta-cells, potentially through nitric oxide (NO). However, this study found human islets are resistant to cytokine-induced NO, suggesting NO is not the primary mediator of damage in type 1 diabetes.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Cytokines are implicated in beta-cell damage in type 1 diabetes, possibly via nitric oxide (NO) generation.
  • Previous research relied on rodent models and heterologous cytokine preparations, necessitating studies on human islets.

Purpose of the Study:

  • To investigate the effects of human recombinant cytokines on NO production and beta-cell function in human pancreatic islets.
  • To determine if NO mediates cytokine-induced beta-cell dysfunction in humans.

Main Methods:

  • Human pancreatic islets from 30 donors were exposed to various cytokines (IFN-gamma, TNF-alpha, IL-6, IL-1 beta) alone and in combination for 6-144 hours.
  • Nitrite production, inducible NO synthase mRNA expression, glucose-induced insulin release, and insulin content were measured.
  • The effects of NO generation inhibitors (aminoguanidine, NG-nitro-L-arginine) were assessed.

Main Results:

  • Combinations of IL-1 beta, IFN-gamma, and TNF-alpha increased NO production and inducible NO synthase mRNA expression in human islets.
  • These cytokines significantly decreased insulin content but did not impair glucose-stimulated insulin release.
  • NO generation inhibitors blocked NO production but did not prevent the suppressive effects on insulin release and content, indicating NO is not the major mediator.

Conclusions:

  • Isolated human islets exhibit greater resistance to cytokine-induced damage compared to rodent islets.
  • Nitric oxide is not the primary mediator of cytokine-induced beta-cell dysfunction in human islets.
  • These findings challenge the prevailing hypothesis regarding NO's role in human type 1 diabetes pathogenesis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...